Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round:

Applied Materials (AMAT) : "I like Applied Materials. It's good."

Okta (OKTA) : "I'm sticking with VMware (VMW) ."

Kemet (KEM) : "That's a cheap stock. I don't have a catalyst, but I like it. "

Lumentum Holdings (LITE) : "No, I prefer Finisar (FNSR) ."

Snap (SNAP) : "No, I'm staying away from Snap."

Teva Pharmaceuticals (TEVA) : "No, don't touch that one."

Over on Real Money, Cramer says Janet Yellen's transparency has been good for markets. Get more on Cramer's insights with a free trial subscription to Real Money.

Cramer and the AAP team take a close look at the central bank's sentiment on future rate hikes. Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

To read a full recap of this episode of "Mad Money," click here.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

More of What's Trending on TheStreet:

At the time of publication, Cramer's Action Alerts PLUS had no position in stocks mentioned.

More from Jim Cramer

Biotech's Coming Back to Life: Cramer's 'Off the Charts'

Biotech's Coming Back to Life: Cramer's 'Off the Charts'

Jim Cramer: Bank of America Expects 4% Economic Growth in Q2

Jim Cramer: Bank of America Expects 4% Economic Growth in Q2

Illinois Tool Works, Deutsche Bank, ForeScout: 'Mad Money' Lightning Round

Illinois Tool Works, Deutsche Bank, ForeScout: 'Mad Money' Lightning Round

Market Refuses To Go Lower: Cramer's 'Mad Money' Recap (Tuesday 7/17/18)

Market Refuses To Go Lower: Cramer's 'Mad Money' Recap (Tuesday 7/17/18)

Jim Cramer on Johnson & Johnson's Pharmaceuticals Sales Growth

Jim Cramer on Johnson & Johnson's Pharmaceuticals Sales Growth